• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Model Number FA-71425-30
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/01/2017
Event Type  Injury  
Manufacturer Narrative
Srinivasan, v.M.Et al.(2017).Prolapse of the pipeline embolization device in aneurysms: incidence, management, and outcomes.Neurosurgical focus, 42(6).Doi:10.3171/2017.3.Focus1738 the pipeline device remains implanted in the patient; product analysis cannot be performed.The reported event could not be confirmed; an event cause could not be conclusively determined from the reported information.Mdrs related to this article: 2029214-2017-00862 2029214-2017-00863 2029214-2017-00864.
 
Event Description
Medtronic literature review found a report of pipeline braid foreshortening during placement.The purpose of this article was to determine the incidence of pipeline (ped) foreshortening or migration leading to prolapse as well as to review rescue strategies and outcomes.The authors identified three cases of ped foreshortening leading to prolapse.In case 2, the patient underwent ped implantation in the treatment of a giant right cavernous ica aneurysm (21 x 29 mm, 7.7-mm neck).The patient was symptomatic with symptoms of right-hemisphere ischemia, and had failed previous attempts at a balloon test occlusion (bto) and extracranial-intracranial bypass.The article states that the ped took a tortuous path through the aneurysm and left a short proximal landing zone (3.1 mm).The ped was inadvertently bumped by the microcatheter during recapture of the distal wire; the proximal ped foreshortened and prolapsed into the aneurysm.Distal access was also lost at the same time.Attempts at regaining access, both anterograde, and retrograde through the posterior communicating artery (pcoa), were unsuccessful.A snare was also used in an attempt to pull the distal stent into the aneurysm to allow deployment of a new device, also unsuccessfully.The device was left in situ with the proximal ped in the aneurysm.The patient was maintained on 81 mg of aspirin daily after receiving dual antiplatelet therapy for 1 year.The patient was clinically asymptomatic at the 30-month follow-up, with no change in the aneurysm on follow-up cta.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE EMBOLIZATION DEVICE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9496801224
MDR Report Key6696944
MDR Text Key79518937
Report Number2029214-2017-00863
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100018.S004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 06/12/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/10/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFA-71425-30
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/12/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age63 YR
-
-